American Journal of Drug and Alcohol Abuse

SJR Rank #5,138H-index: 88SJR: 0.970Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor & Francis Group LLC Philadelphia

Country

United States

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Clinical PsychologyQ1
  • Medicine (miscellaneous)Q1
  • Psychiatry and Mental HealthQ2

Areas: Medicine · Psychology

Most published research topics

Substance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentNeurotransmitter Receptor Influence on BehaviorAlcohol Consumption and Health EffectsHIV, Drug Use, Sexual RiskHomelessness and Social IssuesPrenatal Substance Exposure EffectsCannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisSmoking Behavior and Cessation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs060120180240

Documents per Year

202220250255075100

Detailed Information

ISSN

1097-9891, 0095-2990

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

2.75

References per Document

50.06

Coverage

1974-1982, 1984-2026

Scope

The American Journal of Drug and Alcohol Abuse (AJDAA) is an international journal published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. AJDAA includes a wide range of translational research, covering preclinical and clinical aspects of the field. AJDAA covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration. Areas of particular interest include: public health policy; novel research methodologies; human and animal pharmacology; human translational studies, including neuroimaging; pharmacological and behavioral treatments; new modalities of care; molecular and family genetic studies; medicinal use of substances traditionally considered substances of abuse.

Metrics from SCImago Journal Rank 2025. View on SCImago